Oral administration of methylergometrine shows a late and unpredictable effect on the non-pregnant human menstruating uterus
Autor: | Tom B. Vree, A.N.J.A. de Groot, P.W.J. van Dongen, Tom K.A.B. Eskes |
---|---|
Jazyk: | angličtina |
Rok vydání: | 1995 |
Předmět: |
Technology
Economics Uterus Administration Oral Physiology Pharmacy Acid-Base Imbalance Fetal Distress Biopharmaceutics Menstruation Uterine Contraction Analysis of Collective Decision-Making Oral administration Reproduction Techniques Reproductive Control Agents (Non MeSH) Fetal Monitoring GeneralLiterature_REFERENCE(e.g. dictionaries encyclopedias glossaries) Methylergometrine Brain Diseases Education Medical Reproduction Late effect Obstetrics and Gynecology Brain Fetal Diseases medicine.anatomical_structure Female Genital Diseases and Pregnancy Complications (Non MeSH) Injections Intravenous Pharmacology Clinical Female medicine.symptom Half-Life medicine.drug Adult medicine.medical_specialty Research on anesthesia pain and control of these Cmax Fertilization in Vitro Education Fertility Agents Clinical Fetus Methylergonovine Pharmacokinetics Drug Therapy Internal medicine Medical Evaluation Studies Pressure medicine Humans Technology Pharmaceutical Economics Pharmaceutical Pharmacology business.industry Pharmacoepidemiology Estrogens Fertility Agents Female Outcome and Process Assessment (Health Care) Bioavailability Culture Media Pregnancy Complications Kinetics Endocrinology Overig onderzoek betreffende anesthesie pijn en de sturing daarvan Reproductive Medicine Infertility Pharmaceutical business Sleep Estimation Gonadotropins |
Zdroj: | European Journal of Obstetrics & Gynecology and Reproductive Biology, 60, 101-107 European Journal of Obstetrics & Gynecology and Reproductive Biology, 60, pp. 101-107 European Journal of Obstetrics & Gynecology and Reproductive Biology, 60, 2, pp. 101-107 |
ISSN: | 0301-2115 |
Popis: | Objective: To study the pharmacodynamic and pharmacokinetic properties of oral and intravenous methylergometrine upon uterine motility during menstruation. Study-design: Intra-uterine pressure was measured in six volunteers with a fluid-filled sponge-tipped catheter during menstruation. Methylergometrine was given orally (0.5 mg) or intravenously (0.2 mg) in a cross-over design. Results: After intravenous administration, a fast increase of the frequency of uterine contractions and basal tone occurred with a decrease of amplitude, lasting at least 30 min. Oral administration had a late and less marked effect on uterine motility. An intravenous dose administered 24 h after an oral dose had no effect on uterine motility. Pharmacokinetic data, such as the maximum plasma concentration (Cmax), the time at which Cmax is reached (tmax) and the half-life of absorption ( t 1 2abs ) also demonstrated large individual variations after oral administration. Conclusion: Oral administration of methylergometrine had an unpredictable and late effect on uterine motility on the menstruating uterus, probably due to an unpredictable bioavailability, in contrast with the fast and predictable effect after intravenous administration. |
Databáze: | OpenAIRE |
Externí odkaz: |